À̼ҿµ ±³¼ö
Àü¹®Áø·áºÐ¾ß
¼Ò¾Æ±â Ư¹ß¼º °üÀý¿°, Àü½Å¼º È«¹Ý¼º ·çǪ½º, Ç÷°ü¿°, º£Ã¼Æ®º´, ¼î±×·»º´, Å©¸®¿ÀÇǸ° °ü·Ã ¹ß¿ ÁõÈıº, ÀÏÂ÷¼º ¸é¿ª°áÇÌÁúȯ, ±âŸ ÀÚ°¡¸é¿ª/¿°Áõ Áúȯ
À̼ҿµ ±³¼ö
¼Ò¾Æ±â Ư¹ß¼º °üÀý¿°, Àü½Å¼º È«¹Ý¼º ·çǪ½º, Ç÷°ü¿°, º£Ã¼Æ®º´, ¼î±×·»º´, Å©¸®¿ÀÇǸ° °ü·Ã ¹ß¿ ÁõÈıº, ÀÏÂ÷¼º ¸é¿ª°áÇÌÁúȯ, ±âŸ ÀÚ°¡¸é¿ª/¿°Áõ Áúȯ
Áø·á½Ã°£ | ¿ù | È | ¼ö | ¸ñ | ±Ý | Åä |
---|---|---|---|---|---|---|
¿ÀÀü | ¿Ü·¡Áø·á | |||||
¿ÀÈÄ | ¿Ü·¡Áø·á |
2008.09 ~ 2010.08¼¿ï´ëÇб³ ¸é¿ªÇÐ ¼®»ç 2011.04 ~ 2014.03¿À»çÄ«´ëÇб³ »ý¸í±â´ÉÇÐ ¹Ú»ç 1996.03 ~ 2002.02ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ Á¹¾÷ |
2023.02 ~ ÇѸ²´ëÇб³¼º½Éº´¿ø ¼Ò¾Æû¼Ò³â°ú ÀÓ»óºÎ±³¼ö 2021.03 ~ 2023.01¢ßÁö³ðÀλçÀÌÆ® Èñ±ÍÁúȯÀÇ ÀüÀåÀ¯Àüü ºÐ¼® ÆÀÀå 2017.03 ~ 2021.02¼¿ï´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú ¸é¿ªºÐ°ú Áø·á±³¼ö 2016.03 ~ 2016.11ÀÌÈ¿©´ë ÀÇ°ú´ëÇÐ ¹Ú»çÈÄ ¿¬±¸ ±³¼ö 2015.03 ~ 2016.02ÀÌÈ¿©´ë¸ñµ¿º´¿ø ¼Ò¾Æû¼Ò³â°ú ¼Ò¾Æ°¨¿° ÀüÀÓÀÇ 2014.04 ~ 2015.01Post-doctroal fellowship Immunology Frontier Research Center, Osaka University 2011.04 ~ 2014.03Specially appointed researcher, Immunology Frontier Research Center, Osaka University 2010.06 ~ 2011.04Fellowship of Takeda Science Foundation, Osaka, Japan 2008.03 ~ 2010.06¼¿ï´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú ¸é¿ªºÐ°ú ÀÓ»ó°»ç 2004.03 ~ 2008.02¼¿ï´ëÇб³º´¿ø ¼Ò¾Æû¼Ò³â°ú Àü°øÀÇ 2002.03 ~ 2003.02¼¿ï´ëÇб³º´¿ø ÀÎÅÏ |
2019.09 ~ ´ëÇÑÀÇÇÐÀ¯ÀüÇÐȸ ÁØȸ¿ø 2019.11 ~ Clinical Immunology Society 2018.05 ~ Europena society for Immunodeficiencies 2017.04 ~ 2018.08´ëÇѼҾÆÀÓ»ó¸é¿ªÇÐȸ Ãѹ«ÀÌ»ç 2015.03 ~ ´ëÇѼҾư¨¿°ÇÐȸ Á¤È¸¿ø 2008.03 ~ ´ëÇѸ鿪ÇÐȸ ȸ¿ø 2008.03 ~ ´ëÇѼҾÆÀÓ»ó¸é¿ªÇÐȸ Á¤È¸¿ø 2008.02 ~ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ Æò»ýȸ¿ø 2007.07 ~ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Á¤È¸¿ø |
2020The Osaka Medical Research Foundation for Intractable Disease ¿¬±¸»ó 2020GSK ¿ì¼ö ÃÊ·Ï»ó 2015MSD Çмú»ó 2014GSK ¿ì¼ö ÃÊ·Ï»ó 2009GSK ¿ì¼ö ÃÊ·Ï»ó 2003¼¿ï´ëº´¿ø ¿ì¼öÀÎÅÏ»ó |